Lawsuits[edit]

Johnson & Johnson lawsuits[edit]

Beginning in 2003, Boston Scientific and Johnson & Johnson were involved in a series of litigations involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents. The litigation was settled once Boston Scientific agreed to pay $716 million to Johnson & Johnson in September 2009 and an additional $1.73 billion in February 2010.[6]

It was announced in November 2014 that Johnson & Johnson would have another chance for payback after a multibillion dollar trial was set for 20 November 2014. A New York federal court judge would hear the case without a jury to decide whether Boston Scientific should be held liable for the contract breach.[7]

Abbott Labs non-solicitation lawsuit[edit]

In 2013, Abbott Labs accused Boston Scientific of soliciting and hiring one of its stent sales vice presidents and three sales representatives in an allegedly ongoing campaign aimed at "crushing" Abbott's stent operation. Abbott Labs and Boston Scientific are competitors in the medical stent business and Abbott employees allegedly had a non-solicitation clause in their employment agreements.[8]

Restatement[edit]

On Nov 3,1998, Boston Scientific restated its financial results for 1997, as well as its quarterly results for the first three quarters of 1998, due to the occurrence of business irregularities in the operations of its Japanese subsidiary.[10]